Related Experiment Video
Updated: May 12, 2026

13:21
In Vivo Biosensor Tracks Non-apoptotic Caspase Activity in Drosophila
Published on: November 27, 2016
Drosophila activated Cdc42 kinase has an anti-apoptotic function
Jessica A Schoenherr1, J Michelle Drennan, Juan S Martinez
1Department of Biochemistry, Purdue University, West Lafayette, Indiana, United States of America.
Plos Genetics
|May 23, 2012
Summary
Activated Cdc42 kinases (Acks) are crucial in cancer. In Drosophila, Ack shows anti-apoptotic activity, interacting with Drk and Yorkie to promote tissue overgrowth, highlighting its role in cancer development.
Area of Science:
- Cell Biology
- Molecular Biology
- Cancer Research
Background:
- Activated Cdc42 kinases (Acks) are conserved non-receptor tyrosine kinases.
- Increased ACK1 levels and mutations are linked to human cancers and poor prognosis.
- ACK1 regulates epidermal growth factor (EGF) receptor turnover and downstream signaling.
Purpose of the Study:
- To investigate the anti-apoptotic role of Drosophila Ack.
- To identify interacting proteins and pathways modulating Ack activity.
- To understand how Ack signaling contributes to cancer development.
Main Methods:
- Utilized Drosophila as a model organism.
- Investigated Ack anti-apoptotic activity and its dependence on kinase activity and EGF receptor/Ras signaling.
- Identified and characterized Ack interacting proteins, including Drk and Yorkie.
- Assessed the impact of Drk knockdown and Yorkie loss of function on Ack signaling.
Main Results:
- Drosophila Ack exhibits potent anti-apoptotic activity, enhanced by EGF receptor/Ras signaling.
- Ack's pro-survival signaling is independent of EGF-stimulated MAP kinase pathways.
- Drk knockdown impaired Ack survival activity, indicating the importance of Ack localization.
- Yorkie and Ack synergistically promote tissue overgrowth, and Yorkie loss of function disrupts Ack anti-apoptotic signaling.
Conclusions:
- Drosophila Ack possesses significant anti-apoptotic functions that are regulated by EGF receptor signaling and interact with key cancer-related pathways.
- Ack interacts with Drk and Yorkie, suggesting a mechanism where Ack localization and its collaboration with proliferative signals contribute to tissue overgrowth and cancer development.
- These findings elucidate a novel pathway where Ack signaling, when coupled with proliferative signals, can drive cancer progression.
Related Concept Videos
DNA Damage can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Anaphase Promoting Complex
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...

